This inventor holds 2 USPTO granted patents. Top assignee: California Institute of Technology. Active years: 2013-2014.
Location History:
- Lower Templestowea, AU (2013)
- Lower Templestowe, AU (2014)
Company Filing History:
Years Active: 2013-2014
Title: Sonja Jane McKeown: Innovator in Embryonic Cell Research
Introduction
Sonja Jane McKeown is a prominent inventor based in Lower Templestowe, Australia. She has made significant contributions to the field of embryonic cell research, holding 2 patents that focus on innovative methods for isolating specific cell populations.
Latest Patents
Her latest patents include "Nucleic acids encoding FOXD3 promoter and methods to isolate FOXD3 expressing cells." This patent provides DNA enhancer sequences for use in constructs aimed at identifying early-stage embryonic cells. The enhancer sequences can be utilized in conjunction with short-hairpin RNA in a vector construct for endogenously regulated gene knockdowns. Additionally, the disclosed enhancer sequences can be employed to isolate a selected population of early-stage embryonic cells. Another significant patent is "Nucleic acids encoding SOX10 promoter and methods to isolate SOX10 expressing cells." Similar to her previous work, this patent also provides DNA enhancer sequences for identifying early-stage embryonic cells and can be used in parallel with short-hairpin RNA for gene knockdowns.
Career Highlights
Sonja is affiliated with the California Institute of Technology, where she continues her research and development in the field of genetics and embryology. Her work has garnered attention for its potential applications in regenerative medicine and developmental biology.
Collaborations
Some of her notable coworkers include Paola A Betancur and Tatjana Sauka-Spengler, who contribute to her research endeavors and collaborative projects.
Conclusion
Sonja Jane McKeown is a trailblazer in the field of embryonic cell research, with her innovative patents paving the way for advancements in genetic research and applications. Her contributions are vital to understanding and manipulating early-stage embryonic cells for future scientific breakthroughs.